Maxwell Lea

Maxwell is a Managing Director with DFB, and is part of a team that manages DFB’s business interests in pharmaceutical manufacturing and product development. He also plays a lead role in developing, evaluating, structuring and executing new business and investment opportunities. Prior to his current role, Maxwell was Vice President of Corporate Development for DFB, where he led strategic planning, acquisition and growth initiatives across multiple life science and medical technology businesses. For four years prior to its sale, he was a member of the senior management team of Healthpoint Biotherapeutics (a DFB company), leading business development and international sales and marketing. He initially joined DFB as Director of Corporate Finance with responsibility for capital raising and financial planning and analysis for DFB and its portfolio of companies.

Before joining DFB, Maxwell was an investment banker with Bank of America Securities, where he was responsible for the execution of capital raising and M&A transactions in a variety of industries. He currently serves on the boards of Renaissance Acquisition Holdings LLC, Table Top Media LLC, Bio NorthTX, and Tech Fort Worth. He has earned the Chartered Financial Analyst designation, and graduated with a Bachelor of Arts degree from Vanderbilt University and a Master of Business Administration from The Fuqua School of Business at Duke University.